Chemotherapy for esophageal carcinoma Doctors Abroad — Page 2

Associate Professor Muhammed Mustafa Atci specializes in esophageal carcinoma chemotherapy at Liv Hospital Topkapı, with over a decade of oncology experience.

• Member of the American Society of Clinical Oncology (ASCO)
• Published 19+ peer-reviewed articles on oncology treatments
• Specializes in advanced chemotherapy protocols for esophageal carcinoma
• Education Coordinator for Medical Oncology at Cemil Taşcıoğlu City Hospital

Specialized in medical oncology with a decade of experience in treating complex cases. Ercan Ozden focuses on providing personalized chemotherapy for esophageal carcinoma.

• Completed medical oncology subspecialty at Kocaeli University Faculty of Medicine
• Worked at Şırnak State Hospital focusing on medical oncology
• 27 years of experience as an Internal Medicine Specialist before specializing in oncology

Dr. Alemdar specializes in medical oncology with extensive training at Akdeniz University – a leader in cancer care.

• Board-certified in medical oncology since 2018
• Over 20 years of experience focused exclusively on oncology treatment
• Trained at Akdeniz University Hospital – Turkey's premier cancer center
• Specializes in chemotherapy protocols for gastrointestinal cancers

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Assoc. Prof. Atakan Topcu specializes in medical oncology with a focus on solid tumors, including esophageal carcinoma, at Medipol Acibadem District Hospital.

• Published over 50 scientific articles in oncology
• Expert in targeted therapies and immunotherapy
• Member of European Society for Medical Oncology (ESMO)
• Specializes in cancer-related malnutrition and geriatric oncology

Assoc. Prof. Ayşe İrem Yasin specializes in gastrointestinal cancers at Medipol Acibadem District Hospital, with international training in oncology.

• ESMO Board Certified – recognized European oncology standard
• Trained at top institutions including Cleveland Clinic and Harvard
• Fellowship in Medical Oncology from Bezmialem Vakıf University
• Special focus on adenocarcinomas and complex cancer cases

Associate Professor Nail Paksoy leads clinical trials for advanced chemotherapy protocols at Medipol Bahçelievler Hospital.

• ESMO Board Certified in Medical Oncology
• 15 years of experience specializing in gastrointestinal cancers
• Authors multiple publications on chemotherapy outcomes
• Works with latest FDA-approved drug combinations

Dr. Auala Hubert leads the Gastrointestinal Cancer Center at Hadassah Medical Center, specializing in esophageal carcinoma with 36 years of experience of experience.

• Head of Gastrointestinal Cancer Center at Hadassah University Hospital
• Board-certified in Oncology and Radiotherapy
• Member of Israel Society of Clinical Oncology and Israel Cancer Association
• Fluent in English and Hebrew for international patients

Prof. Ben Boursi specializes in gastrointestinal oncology at Sheba Medical Center, with groundbreaking research on microbiome-based cancer therapies.

• Trained at University of Pennsylvania and MD Anderson Cancer Center
• Founder of the ECOG-ACRIN Microbiome Working Group
• Developed predictive models for early cancer detection
• Published in top journals like Science

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Specializes in organ preservation and functional rehabilitation for oral cancer patients – key for esophageal carcinoma quality of life.

• 15 years of experience of surgical oncology experience at HCG Manavata Cancer Centre
• Fellowship-trained in Head & Neck Surgical Oncology
• Proficient in major maxillofacial and head & neck surgeries
• Focus on preventive oral hygiene and early cancer diagnosis

Dr. Raj Nagarkar has performed 50,000+ cancer surgeries, specializing in Breast and Thoracic Surgical Oncology at HCG Manavata Cancer Centre.

• 30 years of experience of surgical oncology experience
• Trained at Tata Memorial Hospital and Royal College of Surgeons
• Involved in 200+ clinical trials
• Professor for DNB Superspecialty Surgical Oncology

Dr. Shaunak Valame specializes in chemotherapy for esophageal carcinoma with a strong focus on targeted therapies and molecular research.

• Trained in Medical Oncology at Indraprastha Apollo Hospital
• Presented research on stomach cancer at ASCO symposium
• Experienced in both clinical practice and academia

10,000+ major surgeries performed over 15 years of experience – Dr. Banswal specializes in gastrointestinal cancer surgery with a focus on minimally invasive techniques.

• Fellowship-trained in surgical oncology at Tata Medical Centre
• Expert in minimally invasive cancer surgeries with excellent outcomes
• Co-principal investigator in multiple original research projects
• Published in national and international journals

Dr. Shruti Kate specializes in advanced chemotherapy for esophageal carcinoma, with expertise in immunotherapy and metronomic therapy. Trained at Tata Memorial Hospital – one of India's top cancer centers.

• DM in Medical Oncology from Tata Memorial Hospital, Mumbai
• Member of ASCO, ESMO, and other leading oncology societies
• Presented research at the World Conference on Lung Cancer
• Experience treating solid tumors, including lung and esophageal cancers

Handled more than 30,000 PET scans and 1,000 thyroid cancer patients – Dr. Borde specializes in nuclear medicine at HCG Manavata Cancer Centre.

• 11 years of experience of experience in nuclear medicine
• Proficiency in radioiodine & Lu-177 RN therapies
• Published papers in various medical journals